R. Maisano

1.3k total citations
47 papers, 541 citations indexed

About

R. Maisano is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Cancer Research. According to data from OpenAlex, R. Maisano has authored 47 papers receiving a total of 541 indexed citations (citations by other indexed papers that have themselves been cited), including 31 papers in Oncology, 14 papers in Pulmonary and Respiratory Medicine and 10 papers in Cancer Research. Recurrent topics in R. Maisano's work include Cancer Treatment and Pharmacology (13 papers), Colorectal Cancer Treatments and Studies (12 papers) and Breast Cancer Treatment Studies (9 papers). R. Maisano is often cited by papers focused on Cancer Treatment and Pharmacology (13 papers), Colorectal Cancer Treatments and Studies (12 papers) and Breast Cancer Treatment Studies (9 papers). R. Maisano collaborates with scholars based in Italy, United States and Japan. R. Maisano's co-authors include Stefano Pergolizzi, Stefano Cascinu, Vincenzo Adamo, Filippo La Torre, Mario Nardi, Nicola Settineri, Giuseppe Altavilla, Rocco Giannicola, Marcello Aragona and Pietro Del Medico and has published in prestigious journals such as Journal of Clinical Oncology, International Journal of Molecular Sciences and British Journal of Cancer.

In The Last Decade

R. Maisano

46 papers receiving 522 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
R. Maisano Italy 15 312 170 125 85 76 47 541
Toshifumi Doi Japan 13 287 0.9× 298 1.8× 170 1.4× 97 1.1× 190 2.5× 59 799
Ji Hyun Lee South Korea 11 331 1.1× 162 1.0× 117 0.9× 99 1.2× 83 1.1× 49 544
Elena Del Ferro Italy 14 277 0.9× 102 0.6× 87 0.7× 49 0.6× 83 1.1× 22 794
Ping‐Tsung Chen Taiwan 14 201 0.6× 126 0.7× 120 1.0× 59 0.7× 69 0.9× 35 436
Atsushi Takeshita Japan 13 279 0.9× 140 0.8× 154 1.2× 40 0.5× 103 1.4× 40 580
J.M. Gornet France 11 359 1.2× 182 1.1× 284 2.3× 38 0.4× 35 0.5× 24 801
Hyun Soo Ahn South Korea 15 113 0.4× 185 1.1× 181 1.4× 45 0.5× 77 1.0× 55 599
Yasuaki Kuwata Japan 12 182 0.6× 154 0.9× 249 2.0× 75 0.9× 68 0.9× 31 699
Yassine Lalami Belgium 13 441 1.4× 159 0.9× 95 0.8× 58 0.7× 123 1.6× 35 656
Marion Dhooge France 15 208 0.7× 138 0.8× 145 1.2× 63 0.7× 73 1.0× 51 581

Countries citing papers authored by R. Maisano

Since Specialization
Citations

This map shows the geographic impact of R. Maisano's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by R. Maisano with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites R. Maisano more than expected).

Fields of papers citing papers by R. Maisano

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by R. Maisano. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by R. Maisano. The network helps show where R. Maisano may publish in the future.

Co-authorship network of co-authors of R. Maisano

This figure shows the co-authorship network connecting the top 25 collaborators of R. Maisano. A scholar is included among the top collaborators of R. Maisano based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with R. Maisano. R. Maisano is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Giuffrida, Dario, et al.. (2017). Oral sucrosomial iron versus intravenous iron in anemic cancer patients without iron deficiency receiving darbepoetin alfa: a pilot study. Supportive Care in Cancer. 25(9). 2779–2786. 41 indexed citations
2.
Scelzi, E., Daniela Bernardi, Giorgio Bonciarelli, et al.. (2015). Biosimilar epoetin alfa in the management of chemotherapy-induced aneamia: results from ANEMONE observational study. Annals of Oncology. 26. vi121–vi121. 1 indexed citations
3.
Maisano, R., et al.. (2012). Mucinous histology of colon cancer predicts poor outcomes with FOLFOX regimen in metastatic colon cancer. Journal of Chemotherapy. 24(4). 212–216. 39 indexed citations
4.
5.
6.
Maisano, R., et al.. (2008). Oral Vinorelbine as First Line Chemotherapy in Unfit Elderly Patients with Hormone-Refractory Prostate Cancer. Journal of Chemotherapy. 20(3). 368–373. 2 indexed citations
7.
Adamo, Vincenzo, et al.. (2008). Current knowledge and future directions on bisphosphonate-related osteonecrosis of the jaw in cancer patients. Expert Opinion on Pharmacotherapy. 9(8). 1351–1361. 15 indexed citations
8.
Nardi, Marco, et al.. (2007). FOLFOX-4 Regimen as First-Line Chemotherapy in Elderly Patients with Advanced Gastric Cancer: A Safety Study. Journal of Chemotherapy. 19(1). 85–89. 21 indexed citations
9.
Maisano, R., et al.. (2006). Mitomycin C and capecitabine combination (MiXe) in heavily pretreated metastatic breast cancer patients. A dose-finding study.. PubMed. 25(6C). 4513–7. 7 indexed citations
10.
Maisano, R., et al.. (2005). A Modified Weekly Docetaxel Schedule as First-Line Chemotherapy in Elderly Metastatic Breast Cancer: A Safety Study. Journal of Chemotherapy. 17(2). 242–246. 10 indexed citations
11.
Maisano, R., et al.. (2003). Venous damage prevention by defibrotide in vinorelbine-treated patients. Supportive Care in Cancer. 11(9). 593–596. 10 indexed citations
12.
Cascinu, Stefano, Anna Maria Baldelli, Vincenzo Catalano, et al.. (2002). Infusional 5-fluorouracil, cisplatin and mitomycin C in advanced gastric cancer: A low cost effective regimen. British Journal of Cancer. 86(2). 213–217. 12 indexed citations
13.
Pergolizzi, Stefano, Nicola Settineri, Anna Santacaterina, et al.. (2001). Ipsilateral supraclavicular lymph nodes metastases from breast cancer as only site of disseminated disease. Chemotherapy alone vs. induction chemotherapy to radical radiation therapy. Annals of Oncology. 12(8). 1091–1095. 14 indexed citations
14.
Maisano, R., Stefano Pergolizzi, & Stefano Cascinu. (2001). Novel therapeutic approaches to cancer patients with bone metastasis. Critical Reviews in Oncology/Hematology. 40(3). 239–250. 32 indexed citations
15.
Casella, Giovanni, et al.. (2001). Complete regression of primary gastric MALT-lymphoma after double eradication Helicobacter pylori therapy: role and importance of endoscopic ultrasonography.. PubMed. 21(2B). 1499–502. 10 indexed citations
16.
Aragona, Marcello, et al.. (2000). Telomere length maintenance in aging and carcinogenesis.. International Journal of Oncology. 17(5). 981–9. 39 indexed citations
17.
Pergolizzi, Stefano, Nicola Settineri, Anna Santacaterina, et al.. (1999). Prognostic factors in ambulatory patients with inoperable locoregionally recurrent rectal cancer following curative surgery.. PubMed. 19(2B). 1383–90. 6 indexed citations
18.
Scimone, Antonino, R. Maisano, Giuseppe Altavilla, et al.. (1999). Etoposide,l-Leucovorin and Fluorouracil (ELF) Regimen in Metastatic Gastric Cancer: A Phase II Study. Journal of Chemotherapy. 11(1). 74–77. 6 indexed citations
19.
Adamo, Vincenzo, R. Maisano, Stefano Pergolizzi, et al.. (1997). Bleomycin, Epirubicin, Carboplatin (BECA) in the Treatment of Recurrent and/or Metastatic Squamous Cell Carcinoma of the Head and Neck. Journal of Chemotherapy. 9(1). 72–76. 3 indexed citations
20.
Maisano, R., Vincenzo Adamo, Nicola Settineri, et al.. (1996). Efficacy of two oral dose regimens of granisetron.. PubMed. 15(5B). 2287–90. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Toshifumi Doi Breakdown of academic impact, for papers by Ji Hyun Lee Breakdown of academic impact, for papers by Elena Del Ferro Breakdown of academic impact, for papers by Ping‐Tsung Chen Breakdown of academic impact, for papers by Atsushi Takeshita Breakdown of academic impact, for papers by J.M. Gornet Breakdown of academic impact, for papers by Hyun Soo Ahn Breakdown of academic impact, for papers by Yasuaki Kuwata Breakdown of academic impact, for papers by Yassine Lalami Breakdown of academic impact, for papers by Marion Dhooge
Rankless by CCL
2026